Comparison of underdilated versus standard transjugular intrahepatic portosystemic shunt in preventing rebleeding from oesophagogastric varices in patients with cirrhosis in Chinese tertiary hospitals: protocol for a multicentre randomised controlled trial (UVR-TIPS trial)
Open Access
Abstract
Introduction: Hepatic encephalopathy (HE) is a major complication following transjugular intrahepatic portosystemic shunt (TIPS) placement, significantly affecting patients’ quality of life and long-term prognosis. This study aims to compare the efficacy of underdilated TIPS versus standard TIPS in preventing variceal rebleeding in patients with cirrhosis and portal hypertension and to evaluate the incidence of post-procedural HE. Methods and analysis: This multicentre randomised controlled trial will be conducted across five Grade A tertiary hospitals in China. A total of 648 patients with portal hypertension-related oesophagogastric variceal bleeding undergoing TIPS will be enrolled and randomly assigned in a 1:1 ratio to either the experimental or control group. In the experimental group, underdilated TIPS will be performed using 6 mm balloon for stent expansion. In the control group, standard TIPS will be performed using progressive balloon dilation, starting at 8 mm and increasing stepwise as needed until the portosystemic pressure gradient is reduced to <12 mm Hg. The primary endpoint is the rebleeding rate over the entire follow-up period after TIPS. Secondary endpoints include the incidence of HE and liver function impairment. All statistical analyses will be performed using SPSS V.27.0 (IBM, Armonk, New York, USA), with a significance level set at p<0.05. Ethics and dissemination: The study protocol (V.2, 1 July 2025) has been approved by the Medical Ethics Committee of the First Affiliated Hospital of Air Force Medical University (Approval No.: KY20252233-F-2). Written informed consent will be obtained from all participants prior to enrolment. Findings will be presented at academic conferences and published in peer-reviewed journals. Trial registration number: ChiCTR2500110490; NCT07253389 .Keywords
Funding Information
- the New Clinical Technology Project of Xijing Hospital (Grant No. 2024XJSM08)
This publication has 22 references indexed in Scilit:
- Effect of underdilated transjugular intrahepatic portosystemic shunt on prognosis in patients with prior splenectomy: a propensity score-matched case–control studyAbdominal Radiology, 2022
- EASL Clinical Practice Guidelines on the management of hepatic encephalopathyJournal of Hepatology, 2022
- Hepatic Encephalopathy After TIPS Placement: Predictive Factors, Prevention Strategies, and ManagementCardioVascular and Interventional Radiology, 2022
- Eight millimetre covered TIPS does not compromise shunt function but reduces hepatic encephalopathy in preventing variceal rebleedingJournal of Hepatology, 2017
- Covered transjugular intrahepatic portosystemic shunt versus endoscopic therapy + β‐blocker for prevention of variceal rebleedingHepatology, 2015
- Shunt dysfunction: Is it suitable as the primary end point in transjugular intrahepatic portosystemic shunt trials?Journal of Hepatology, 2015
- Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic ShuntClinics in Liver Disease, 2012
- Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosisJournal of Hepatology, 2011
- Revising consensus in portal hypertension: Report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertensionJournal of Hepatology, 2010
- Clinical efficacy of transjugular intrahepatic portosystemic shunt created with covered stents with different diameters: Results of a randomized controlled trialJournal of Hepatology, 2010